Indeed, activation of its receptor, the mineralocorticoid receptor (MR), has been shown to induce endothelial dysfunction, inflammation, remodeling, stiffening and atherosclerosis (82–88). The gene discussed is NR3C2; the disease is endothelial dysfunction.